Norman Ruchholtz
Vorstandsvorsitzender bei Cantourage GmbH
Profil
Norman Ruchholtz is associated with two companies, Cantourage Group SE and Cantourage GmbH, both of which he founded in 2019.
At Cantourage GmbH, he holds the title of Managing Director.
Aktive Positionen von Norman Ruchholtz
| Unternehmen | Position | Beginn |
|---|---|---|
Cantourage GmbH
 Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Vorstandsvorsitzender | 01.01.2019 |
Ehemalige bekannte Positionen von Norman Ruchholtz
| Unternehmen | Position | Ende |
|---|---|---|
| CANTOURAGE GROUP SE | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANTOURAGE GROUP SE | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Cantourage GmbH
Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Health Technology |
